Liang Hu

11PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 11, 2025
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer.

Jun Lu, Minjuan Hu, Yikai Zhao

|Jul 04, 2025
Comprehensive analysis of a real-world cohort identifies geranylgeranyl diphosphate synthase 1 as a predictor of chemoresistance in small cell lung cancer.

Yi Deng, Chenchen Guo, Tengfei Zhang

|Dec 17, 2024
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target.

Hua Wang, Shijie Tang, Qibiao Wu

|May 28, 2024
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.

Yun Xue, Yuting Chen, Sijia Sun

|Jan 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.

Zhen Qin, Meiting Yue, Shijie Tang

|Dec 29, 2023
Correction to: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Yujuan Jin, Qiqi Zhao, Weikang Zhu

Pageof 2

Frequent Collaborators

10 joint publications

Hongbin Ji

7 joint publications

Luonan Chen

3 joint publications

Kwok-Kin Wong

2 joint publications

Hsinyi Huang